NewsBenzingaItron、第3四半期調整後EPSが1.94ドルで予想の1.56ドルを上回る 売上高は5億9,933万3,000ドルで予想の5億9,584万5,000ドルを上回る Itron、第3四半期調整後EPSが1.94ドルで予想の1.56ドルを上回る 売上高は5億9,933万3,000ドルで予想の5億9,584万5,000ドルを上回る Benzinga 2026.10.27 12:36 (GMT+0) Open on Benzinga Other news Keybanc Reiterates Sector Weight on NVIDIAto Sector Weight Top 3 Tech Stocks That May Fall Off A Cliff This Month Truist Securities Maintains Hold on BILL Holdings, Raises Price Target to $66 Nvidia’s China Exit Could Trigger a Bull-Bear Showdown: 6 Leveraged ETFs to Watch Wednesday OTraces Selects Labcorp To Perform Reference Laboratory Testing For Florida Department Of Health–Funded Clinical Trial Evaluating OTraces Blood-Based Prostate Cancer Diagnostic Platform Quanterix Affirms FY2026 Sales Guidance of $142.000M-$146.000M vs $143.357M Est
OTraces Selects Labcorp To Perform Reference Laboratory Testing For Florida Department Of Health–Funded Clinical Trial Evaluating OTraces Blood-Based Prostate Cancer Diagnostic Platform